Lionel Rousseau, a co-founder of the Neurallys and researcher at ESIEE Paris has stood out during the 3rd Start-up in Paris. Co-hosted by Challenges et Sciences and Avenir, this event was held at the Palais Brongniart April 11th.
Neurallys among the 5 finalists !
Challenge received around 100 applicants and from that, 5 were chosen. Neurallys was placed in the ‘Biotech and Health’ Category.
Initiated by a research project carried out at ESIEE Paris in collaboration with Pitié-Salpêtrière, Neurallys is a start-up dedicated to the field of brain surgery. It has an aim of creating devices which can improve the life conditions of patients and assist with the work of professionals.
The start-up Neurallys was established through the meeting of three specialists : Professor Philippe Cornu, Neurosurgeon at la Pitié-Salpêtrière, Lionel Rousseau, Doctor and Researcher in Microelectronics within ESIEE Paris, specialist in sensors and microsystems applied in the medical world, in particular implants and Mr Philippe Auvray, CEO of Neurallys (previously of Philips Semiconductor). Together, they have developed a medical device allowing better care for patients suffering from Hydrocephalus, an unknown yet widespread disease. Due to a congenital disease or serious head injury (Meningitus, CVA, a tumour), this disease affects 100,000 to 150,000 people in France. If left untreated, it can be fatal..
The treatment consists of placing a valve within the skull which allows the continuous flow of water to prevent it from accumulating in an abnormal way and increasing the cranial cavity.
Neurallys has developed a device which continuously measures the cranial cavities pressure. Connected to the patients smartphone, the implant –installed at the same time as the valve – is capable of reassuring or alerting the patient in the case of a problem but also to help the surgeon to make a diagnosis.